
Genie 4 and AI-assisted drug programmes can multiply plausible candidates. The advantage moves to organisations that can test them honestly.
The argument
When generated candidates outpace trustworthy tests, advantage shifts towards organisations that can make proposals collide with independent evidence.
What is new
Genie 4 creates short steerable audiovisual worlds. Anthropic’s partners report AI-assisted designs entering laboratory loops, including tens of thousands of antibody candidates.
Why it matters
Laboratories, controlled pilots and expert attention remain scarce. The decisive capability is choosing tests that expose mistaken assumptions rather than reward plausible demonstrations.
LecXie’s practical interpretation
Preserve candidate lineage, select experiments for information, separate maker and judge, reserve physical capacity and publish the transfer gap.
Evidence & limits
Genie 4 remains a trusted-tester preview. Anthropic’s reports are mostly preclinical collaborations and cannot isolate Claude’s contribution from people, laboratories and data systems.
